Guggenheim Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19.8M | Sell |
191,531
-11,821
| -6% | -$1.06M | 0.12% | 148 |
|
|
2026
Q1 | $14.6M | Sell |
203,352
-9,970
| -5% | -$768K | 0.11% | 190 |
|
|
2025
Q4 | $16.9M | Sell |
213,322
-100,538
| -32% | -$7.93M | 0.12% | 162 |
|
|
2025
Q3 | $23.7M | Buy |
313,860
+27,961
| +10% | +$1.92M | 0.17% | 118 |
|
|
2025
Q2 | $19.7M | Sell |
285,899
-19,880
| -7% | -$1.3M | 0.16% | 121 |
|
|
2025
Q1 | $20.7M | Sell |
305,779
-47,880
| -14% | -$2.87M | 0.19% | 106 |
|
|
2024
Q4 | $15.9M | Sell |
353,659
-13,185
| -4% | -$740K | 0.13% | 154 |
|
|
2024
Q3 | $23.1M | Sell |
366,844
-43,864
| -11% | -$2.56M | 0.16% | 122 |
|
|
2024
Q2 | $24.3M | Sell |
410,708
-5,440
| -1% | -$340K | 0.17% | 109 |
|
|
2024
Q1 | $33.2M | Buy |
416,148
+37,182
| +10% | +$2.84M | 0.23% | 87 |
|
|
2023
Q4 | $29.9M | Buy |
378,966
+46,833
| +14% | +$3.33M | 0.23% | 84 |
|
|
2023
Q3 | $23.2M | Sell |
332,133
-7,370
| -2% | -$522K | 0.2% | 96 |
|
|
2023
Q2 | $23.5M | Sell |
339,503
-28,481
| -8% | -$2.03M | 0.18% | 102 |
|
|
2023
Q1 | $27.3M | Sell |
367,984
-9,509
| -3% | -$797K | 0.23% | 83 |
|
|
2022
Q4 | $35.2M | Sell |
377,493
-4,238
| -1% | -$409K | 0.31% | 62 |
|
|
2022
Q3 | $36.4M | Buy |
381,731
+7,609
| +2% | +$753K | 0.33% | 56 |
|
|
2022
Q2 | $34.7M | Buy |
374,122
+18,176
| +5% | +$1.77M | 0.27% | 67 |
|
|
2022
Q1 | $36M | Sell |
355,946
-4,442
| -1% | -$467K | 0.22% | 86 |
|
|
2021
Q4 | $37.2M | Buy |
360,388
+12,009
| +3% | +$1.11M | 0.19% | 97 |
|
|
2021
Q3 | $29.6M | Sell |
348,379
-10,938
| -3% | -$916K | 0.18% | 104 |
|
|
2021
Q2 | $30M | Sell |
359,317
-2,872
| -0.8% | -$235K | 0.18% | 104 |
|
|
2021
Q1 | $27.2M | Buy |
362,189
+57,674
| +19% | +$4.2M | 0.18% | 105 |
|
|
2020
Q4 | $20.8M | Buy |
304,515
+61,292
| +25% | +$3.99M | 0.13% | 137 |
|
|
2020
Q3 | $14.2M | Sell |
243,223
-49,525
| -17% | -$3.08M | 0.1% | 184 |
|
|
2020
Q2 | $19M | Buy |
292,748
+45,241
| +18% | +$2.85M | 0.15% | 131 |
|
|
2020
Q1 | $14.7M | Sell |
247,507
-62,454
| -20% | -$4.17M | 0.15% | 134 |
|
|
2019
Q4 | $23M | Sell |
309,961
-31,281
| -9% | -$2.2M | 0.17% | 120 |
|
|
2019
Q3 | $21.5M | Sell |
341,242
-19,903
| -6% | -$1.18M | 0.17% | 129 |
|
|
2019
Q2 | $19.7M | Buy |
361,145
+24,712
| +7% | +$1.33M | 0.16% | 129 |
|
|
2019
Q1 | $18.1M | Sell |
336,433
-80,659
| -19% | -$4.98M | 0.15% | 131 |
|
|
2018
Q4 | $27.3M | Sell |
417,092
-54,985
| -12% | -$4.1M | 0.23% | 61 |
|
|
2018
Q3 | $37.2M | Sell |
472,077
-35,067
| -7% | -$2.51M | 0.24% | 51 |
|
|
2018
Q2 | $32.6M | Sell |
507,144
-849,436
| -63% | -$56M | 0.22% | 58 |
|
|
2018
Q1 | $84.4M | Sell |
1,356,580
-30,801
| -2% | -$2.21M | 0.21% | 75 |
|
|
2017
Q4 | $101M | Buy |
1,387,381
+211,571
| +18% | +$15.4M | 0.24% | 45 |
|
|
2017
Q3 | $95.6M | Sell |
1,175,810
-71,108
| -6% | -$5.62M | 0.22% | 41 |
|
|
2017
Q2 | $100M | Sell |
1,246,918
-15,548
| -1% | -$1.23M | 0.27% | 33 |
|
|
2017
Q1 | $99.1M | Buy |
1,262,466
+121,028
| +11% | +$9.66M | 0.27% | 31 |
|
|
2016
Q4 | $90.1M | Buy |
1,141,438
+227,688
| +25% | +$18.4M | 0.26% | 39 |
|
|
2016
Q3 | $81.3M | Buy |
913,750
+14,910
| +2% | +$1.41M | 0.25% | 42 |
|
|
2016
Q2 | $86.1M | Buy |
898,840
+72,925
| +9% | +$7.27M | 0.27% | 37 |
|
|
2016
Q1 | $85.7M | Sell |
825,915
-7,595
| -0.9% | -$738K | 0.27% | 34 |
|
|
2015
Q4 | $81.5M | Sell |
833,510
-170,375
| -17% | -$16.7M | 0.24% | 53 |
|
|
2015
Q3 | $96.9M | Buy |
1,003,885
+53,595
| +6% | +$5.63M | 0.3% | 20 |
|
|
2015
Q2 | $99.7M | Sell |
950,290
-52,173
| -5% | -$5.33M | 0.25% | 32 |
|
|
2015
Q1 | $103M | Sell |
1,002,463
-308,306
| -24% | -$31.2M | 0.24% | 38 |
|
|
2014
Q4 | $126M | Buy |
1,310,769
+120,775
| +10% | +$10.6M | 0.32% | 16 |
|
|
2014
Q3 | $94.7M | Sell |
1,189,994
-32,161
| -3% | -$2.54M | 0.23% | 38 |
|
|
2014
Q2 | $92.1M | Sell |
1,222,155
-180,294
| -13% | -$13.6M | 0.23% | 41 |
|
|
2014
Q1 | $105M | Buy |
1,402,449
+486,644
| +53% | +$34.4M | 0.3% | 17 |
|
|
2013
Q4 | $65.5M | Sell |
915,805
-224,805
| -20% | -$14.4M | 0.2% | 76 |
|
|
2013
Q3 | $64.7M | Buy |
1,140,610
+205,560
| +22% | +$12.2M | 0.23% | 46 |
|
|
2013
Q2 | $53.5M | Buy |
+935,050
| New | +$54.2M | 0.22% | 52 |
|
Other funds holding CVS
Guggenheim Capital's CVS Position: Q2 2026 in Review
Guggenheim Capital reduced its CVS Health (CVS) stake by 5.8% in Q2 2026, selling an estimated $1.06M and leaving 191,531 shares worth $19.8M. The position accounts for 0.12% of the portfolio, ranked #148.
Guggenheim Capital first reported a position in CVS in Q2 2013 and has held it in 53 quarters since. The position peaked at $126M in Q4 2014. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Guggenheim Capital held 191,531 shares of CVS Health worth $19.8M as of Q2 2026.
- Guggenheim Capital sold 11,821 CVS Health shares in Q2 2026, an estimated $1.06M.
- CVS Health made up 0.12% of Guggenheim Capital's portfolio in Q2 2026, its #148 holding.
- Guggenheim Capital first reported a position in CVS Health in Q2 2013 and has held it in 53 quarters since.
- Guggenheim Capital's CVS Health position peaked at $126M in Q4 2014.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Guggenheim Capital's 13F filing for Q2 2026, filed 12 Aug 2026.